MENA - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingMENA: Medicaments Containing Insulin Market 2024
Medicaments Containing Insulin Market Size in MENA
In 2022, the MENA's medicaments containing insulin market was finally on the rise to reach $X for the first time since 2018, thus ending a three-year declining trend. Overall, consumption, however, recorded a abrupt setback. Over the period under review, the market reached the peak level at $X in 2016; however, from 2017 to 2022, consumption stood at a somewhat lower figure.
Medicaments Containing Insulin Production in MENA
In value terms, medicaments containing insulin production expanded to $X in 2022 estimated in export price. Over the period under review, production, however, recorded a mild contraction. The most prominent rate of growth was recorded in 2013 when the production volume increased by X% against the previous year. As a result, production reached the peak level of $X. From 2014 to 2022, production growth remained at a somewhat lower figure.
Looking for Local Partners?
Connect with the right partners to expand your reach.
Book a free 30-minute consultation to find your match.
Medicaments Containing Insulin Exports
Exports in MENA
In 2022, approx. X tons of medicaments containing insulin but not antibiotics were exported in MENA; increasing by X% on the previous year's figure. In general, exports, however, showed a drastic downturn. The most prominent rate of growth was recorded in 2020 when exports increased by X%. Over the period under review, the exports attained the maximum at X tons in 2014; however, from 2015 to 2022, the exports remained at a lower figure.
In value terms, medicaments containing insulin exports plummeted to $X in 2022. Overall, exports, however, continue to indicate a sharp contraction. The pace of growth appeared the most rapid in 2020 with an increase of X%. The level of export peaked at $X in 2012; however, from 2013 to 2022, the exports failed to regain momentum.
Exports by Country
Jordan dominates exports structure, resulting at X tons, which was near X% of total exports in 2022. The following exporters - the United Arab Emirates (X kg), Egypt (X kg), Saudi Arabia (X kg) and Turkey (X kg) - together made up X% of total exports.
Jordan was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics exports, with a CAGR of X% from 2012 to 2022. At the same time, Saudi Arabia (X%) displayed positive paces of growth. By contrast, Turkey (X%), the United Arab Emirates (X%) and Egypt (X%) illustrated a downward trend over the same period. While the share of Jordan (X p.p.), Egypt (X p.p.) and Saudi Arabia (X p.p.) increased significantly in terms of the total exports from 2012-2022, the share of Turkey (X p.p.) and the United Arab Emirates (X p.p.) displayed negative dynamics.
In value terms, the largest medicaments containing insulin supplying countries in MENA were Egypt ($X), Jordan ($X) and the United Arab Emirates ($X), together accounting for X% of total exports.
Jordan, with a CAGR of X%, recorded the highest growth rate of the value of exports, in terms of the main exporting countries over the period under review, while shipments for the other leaders experienced a decline in the exports figures.
Export Prices by Country
The export price in MENA stood at $X per ton in 2022, with a decrease of X% against the previous year. Over the period under review, the export price showed a abrupt decrease. The most prominent rate of growth was recorded in 2021 when the export price increased by X% against the previous year. The level of export peaked at $X per ton in 2012; however, from 2013 to 2022, the export prices remained at a lower figure.
Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Egypt ($X per ton), while Jordan ($X per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Egypt (X%), while the other leaders experienced a decline in the export price figures.
Medicaments Containing Insulin Imports
Imports in MENA
In 2022, purchases abroad of medicaments containing insulin but not antibiotics was finally on the rise to reach X tons after two years of decline. Over the period under review, imports, however, faced a deep reduction. The most prominent rate of growth was recorded in 2015 when imports increased by X% against the previous year. The volume of import peaked at X tons in 2016; however, from 2017 to 2022, imports stood at a somewhat lower figure.
In value terms, medicaments containing insulin imports shrank slightly to $X in 2022. In general, imports, however, faced a abrupt descent. The pace of growth was the most pronounced in 2015 when imports increased by X% against the previous year. The level of import peaked at $X in 2016; however, from 2017 to 2022, imports remained at a lower figure.
Imports by Country
In 2022, Kuwait (X tons) was the largest importer of medicaments containing insulin but not antibiotics, mixing up X% of total imports. Tunisia (X tons) held the second position in the ranking, distantly followed by Iran (X tons). All these countries together held near X% share of total imports. Iraq (X tons) followed a long way behind the leaders.
Kuwait was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics imports, with a CAGR of X% from 2012 to 2022. Iraq (X%), Tunisia (X%) and Iran (X%) illustrated a downward trend over the same period. Kuwait (X p.p.) significantly strengthened its position in terms of the total imports, while Iraq, Iran and Tunisia saw its share reduced by X%, X% and X% from 2012 to 2022, respectively.
In value terms, the largest medicaments containing insulin importing markets in MENA were Kuwait ($X), Tunisia ($X) and Iran ($X), with a combined X% share of total imports.
Kuwait, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced a decline in the imports figures.
Import Prices by Country
The import price in MENA stood at $X per ton in 2022, shrinking by X% against the previous year. Over the period under review, the import price continues to indicate a noticeable contraction. The pace of growth was the most pronounced in 2018 an increase of X% against the previous year. Over the period under review, import prices hit record highs at $X per ton in 2012; however, from 2013 to 2022, import prices failed to regain momentum.
Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Iran ($X per ton), while Kuwait ($X per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Iran (X%), while the other leaders experienced mixed trends in the import price figures.
Source: IndexBox Platform
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the medicaments containing insulin market in MENA. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale
Country coverage:
- Algeria
- Bahrain
- Djibouti
- Egypt
- Iran
- Iraq
- Israel
- Jordan
- Kuwait
- Lebanon
- Libya
- Morocco
- Oman
- Palestine
- Qatar
- Saudi Arabia
- Syrian Arab Republic
- Tunisia
- Turkey
- United Arab Emirates
- Yemen
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Production in MENA, split by region and country
- Trade (exports and imports) in MENA
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- CONSUMPTION BY COUNTRY
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
- PRODUCTION BY COUNTRY
8. IMPORTS
The Largest Importers on The Market and How They Succeed
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Exporters on The Market and How They Succeed
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
11. COUNTRY PROFILES
The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO- Algeria
- Bahrain
- Djibouti
- Egypt
- Iran
- Iraq
- Israel
- Jordan
- Kuwait
- Lebanon
- Libya
- Morocco
- Oman
- Palestine
- Qatar
- Saudi Arabia
- Syrian Arab Republic
- Tunisia
- Turkey
- United Arab Emirates
- Yemen
-
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption, By Country, 2018–2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Destination, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Origin, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Consumption, By Country, 2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Production, By Country, 2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, 2012–2023
Recommended reports
This report provides an in-depth analysis of the medicaments containing insulin market in Asia.
This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..
This report provides an in-depth analysis of the medicaments containing insulin market in China.
This report provides an in-depth analysis of the medicaments containing insulin market in the EU.
This report provides an in-depth analysis of the global medicaments containing insulin market.
- Medicaments Containing Insulin Market
- Chemically Modified Oils Market
- Crude Glycerol Market
- Salicylic Acid Market
- O-acetylsalicylic Acid Market
- Esters of Salicylic Acid and Their Salts Market
- Lysine Market
- Glutamic Acid Market
- Quaternary Ammonium Salts and Hydroxides Market
- Acyclic Amides and Their Derivatives Market